Covered recipient · General Payments record

THOMAS PECHIN

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1972951945
CMS profile: 6554015
Location: GOSHEN, IN

General Payments · PY2019–2024

$3,865.82

Reported across 221 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,397.08

77 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,397.08	77

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
ABBVIE INC.	$182.00	8
Lilly USA, LLC	$175.49	12
Acerta Pharma LLC	$155.07	9
Boehringer Ingelheim Pharmaceuticals, Inc.	$132.02	7
Novo Nordisk AS	$113.54	6
Indivior Inc.	$100.33	6
PFIZER INC.	$94.85	6
Mylan Specialty L.P.	$90.39	4
Amgen Inc.	$66.47	4
Lundbeck LLC	$59.54	3
Phathom Pharmaceuticals, Inc.	$38.18	2
Abbott Laboratories	$35.56	2
Axsome Therapeutics, Inc.	$28.04	1
ITI, Inc.	$20.45	1
Alkermes, Inc.	$19.85	1
Bayer HealthCare Pharmaceuticals Inc.	$19.39	1
Otsuka America Pharmaceutical, Inc.	$19.35	1
GlaxoSmithKline, LLC.	$18.61	1
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$14.59	1
Takeda Pharmaceuticals U.S.A., Inc.	$13.36	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2019	$76.51	5
PY2020	$255.17	17
PY2021	$784.74	46
PY2022	$514.02	29
PY2023	$838.30	47
PY2024	$1,397.08	77

Payment records · PY2024 (77)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$21.31	03/27/2024	Food and Beverage	Undisputed	01/23/2026	1125367183	CMS
Abbott Laboratories	$14.25	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1125367185	CMS
ABBVIE INC.	$30.73	03/13/2024	Food and Beverage	Undisputed	01/23/2026	1105223784	CMS
ABBVIE INC.	$21.13	05/29/2024	Food and Beverage	Undisputed	01/23/2026	1105223788	CMS
ABBVIE INC.	$24.73	06/06/2024	Food and Beverage	Undisputed	01/23/2026	1105223792	CMS
ABBVIE INC.	$23.94	08/23/2024	Food and Beverage	Undisputed	01/23/2026	1105223796	CMS
ABBVIE INC.	$21.03	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1105223800	CMS
ABBVIE INC.	$31.96	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1105223804	CMS
ABBVIE INC.	$16.63	10/16/2024	Food and Beverage	Undisputed	01/23/2026	1105223808	CMS
ABBVIE INC.	$11.85	11/11/2024	Food and Beverage	Undisputed	01/23/2026	1105223812	CMS
Alkermes, Inc.	$19.85	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1120571715	CMS
Amgen Inc.	$15.31	01/03/2024	Food and Beverage	Undisputed	01/23/2026	1117652284	CMS
Amgen Inc.	$15.99	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1117652286	CMS
Amgen Inc.	$18.53	08/05/2024	Food and Beverage	Undisputed	01/23/2026	1117652288	CMS
Amgen Inc.	$16.64	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1117652290	CMS
AstraZeneca Pharmaceuticals LP	$12.37	01/20/2024	Food and Beverage	Undisputed	01/23/2026	1104270413	CMS
AstraZeneca Pharmaceuticals LP	$16.65	02/27/2024	Food and Beverage	Undisputed	01/23/2026	1104313738	CMS
AstraZeneca Pharmaceuticals LP	$16.07	03/02/2024	Food and Beverage	Undisputed	01/23/2026	1104355770	CMS
AstraZeneca Pharmaceuticals LP	$18.56	03/23/2024	Food and Beverage	Undisputed	01/23/2026	1104285725	CMS
AstraZeneca Pharmaceuticals LP	$20.60	07/20/2024	Food and Beverage	Undisputed	01/23/2026	1105360686	CMS
AstraZeneca Pharmaceuticals LP	$23.73	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1104255531	CMS
AstraZeneca Pharmaceuticals LP	$15.65	08/02/2024	Food and Beverage	Undisputed	01/23/2026	1104267167	CMS
AstraZeneca Pharmaceuticals LP	$17.34	09/10/2024	Food and Beverage	Undisputed	01/23/2026	1104198789	CMS
AstraZeneca Pharmaceuticals LP	$14.10	11/08/2024	Food and Beverage	Undisputed	01/23/2026	1105423736	CMS
Axsome Therapeutics, Inc.	$28.04	06/24/2024	Food and Beverage	Undisputed	01/23/2026	1148324959	CMS
Bayer Healthcare Pharmaceuticals Inc.	$19.39	10/15/2024	Food and Beverage	Undisputed	01/23/2026	1086199322	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$20.61	01/08/2024	Food and Beverage	Undisputed	01/23/2026	1118258815	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$19.89	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1118258813	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$7.67	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1118258807	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$18.06	07/22/2024	Food and Beverage	Undisputed	01/23/2026	1118258811	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$21.62	09/23/2024	Food and Beverage	Undisputed	01/23/2026	1118258817	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$14.71	11/13/2024	Food and Beverage	Undisputed	01/23/2026	1118258809	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$29.46	11/18/2024	Food and Beverage	Undisputed	01/23/2026	1118258819	CMS
GlaxoSmithKline, LLC.	$18.61	10/11/2024	Food and Beverage	Undisputed	01/23/2026	1115989315	CMS
Indivior Inc.	$15.92	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1144535337	CMS
Indivior Inc.	$15.28	03/06/2024	Food and Beverage	Undisputed	01/23/2026	1144535339	CMS
Indivior Inc.	$15.30	05/15/2024	Food and Beverage	Undisputed	01/23/2026	1144535341	CMS
Indivior Inc.	$20.95	08/14/2024	Food and Beverage	Undisputed	01/23/2026	1144535343	CMS
Indivior Inc.	$18.41	11/13/2024	Food and Beverage	Undisputed	01/23/2026	1144535345	CMS
Indivior Inc.	$14.47	12/16/2024	Food and Beverage	Undisputed	01/23/2026	1144535347	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$20.45	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1143294294	CMS
Lilly USA, LLC	$12.23	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1135437747	CMS
Lilly USA, LLC	$14.91	02/19/2024	Food and Beverage	Undisputed	01/23/2026	1135462195	CMS
Lilly USA, LLC	$17.43	03/04/2024	Food and Beverage	Undisputed	01/23/2026	1135456765	CMS
Lilly USA, LLC	$11.73	03/08/2024	Food and Beverage	Undisputed	01/23/2026	1135462197	CMS
Lilly USA, LLC	$19.08	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1135456763	CMS
Lilly USA, LLC	$16.15	05/12/2024	Food and Beverage	Undisputed	01/23/2026	1135449328	CMS
Lilly USA, LLC	$13.72	07/07/2024	Food and Beverage	Undisputed	01/23/2026	1135477310	CMS
Lilly USA, LLC	$11.54	07/15/2024	Food and Beverage	Undisputed	01/23/2026	1135462199	CMS
Lilly USA, LLC	$15.15	09/02/2024	Food and Beverage	Undisputed	01/23/2026	1135449326	CMS
Lilly USA, LLC	$12.65	09/19/2024	Food and Beverage	Undisputed	01/23/2026	1135449330	CMS
Lilly USA, LLC	$14.71	10/20/2024	Food and Beverage	Undisputed	01/23/2026	1135456767	CMS
Lilly USA, LLC	$16.19	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1135491796	CMS
Lundbeck LLC	$18.68	02/02/2024	Food and Beverage	Undisputed	01/23/2026	1145955287	CMS
Lundbeck LLC	$23.22	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1145955289	CMS
Lundbeck LLC	$17.64	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1145955291	CMS
Mylan Specialty L.P.	$26.87	06/29/2024	Food and Beverage	Undisputed	01/23/2026	1147290578	CMS
Mylan Specialty L.P.	$29.19	08/10/2024	Food and Beverage	Undisputed	01/23/2026	1147294831	CMS
Mylan Specialty L.P.	$17.38	11/05/2024	Food and Beverage	Undisputed	01/23/2026	1147330806	CMS
Mylan Specialty L.P.	$16.95	12/18/2024	Food and Beverage	Undisputed	01/23/2026	1147360349	CMS
Novo Nordisk Inc	$16.89	01/30/2024	Food and Beverage	Undisputed	01/23/2026	1096985801	CMS
Novo Nordisk Inc	$20.34	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1096663519	CMS
Novo Nordisk Inc	$18.39	06/15/2024	Food and Beverage	Undisputed	01/23/2026	1097187720	CMS
Novo Nordisk Inc	$19.10	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1097593964	CMS
Novo Nordisk Inc	$20.51	09/21/2024	Food and Beverage	Undisputed	01/23/2026	1096901411	CMS
Novo Nordisk Inc	$18.31	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1097147008	CMS
Otsuka America Pharmaceutical, Inc.	$19.35	10/10/2024	Food and Beverage	Undisputed	01/23/2026	1118959667	CMS
PFIZER INC.	$15.03	02/01/2024	Food and Beverage	Undisputed	01/23/2026	1131138667	CMS
PFIZER INC.	$17.80	03/12/2024	Food and Beverage	Undisputed	01/23/2026	1131244510	CMS
PFIZER INC.	$14.96	04/04/2024	Food and Beverage	Undisputed	01/23/2026	1131411544	CMS
PFIZER INC.	$15.80	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1131484291	CMS
PFIZER INC.	$16.75	06/08/2024	Food and Beverage	Undisputed	01/23/2026	1131673145	CMS
PFIZER INC.	$14.51	08/01/2024	Food and Beverage	Undisputed	01/23/2026	1131877242	CMS
Phathom Pharmaceuticals, Inc.	$15.91	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1151108948	CMS
Phathom Pharmaceuticals, Inc.	$22.27	06/21/2024	Food and Beverage	Undisputed	01/23/2026	1151108950	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$14.59	01/24/2024	Food and Beverage	Undisputed	01/23/2026	1153697729	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$13.36	11/25/2024	Food and Beverage	Undisputed	01/23/2026	1137652440	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.